Earnings Preview — 1501 total
VMD Misses on EPS but Lifts Guidance Viemed Healthcare walked into its Q1 2026 print with a clean lending market but a narrative already complicated by insider selling — and the numbers delivered a familiar split…
INMB heads into its May 7 earnings with one of the most aggressive short positions in the biotech universe — and a stock price that has quietly been rallying against it. Short sellers have dug in with real conviction.…
ANGI walks into its May 6 earnings report carrying one of the heavier short burdens in its peer group — yet the bears have been quietly retreating over the past month. Short interest now covers roughly 20.7% of the…
Granite Point Mortgage Trust heads into its Q1 2026 earnings today carrying a pattern of severe post-earnings selloffs that sets the bar for what the market will accept. The historical record is stark. Across the three…
Select Water Solutions heads into its Q1 2026 earnings today with options positioning markedly more defensive than usual, even as short sellers quietly retreat. The clearest signal is in the options market. The…
TRVG heads into its Q1 2026 earnings call — scheduled for today — with one signal dominating all others: an EPS momentum profile that ranks in the top 3% of the market. That is the genuine standout. On both the 30-day…
BlackLine heads into its May 7 Q1 2026 earnings report with short sellers firmly in place and options markets leaning defensively — a combination that frames the print as a test of the company's growth narrative at a…
Global Indemnity Group heads into its May 8 earnings release with a clear insider-buying signal that has persisted through the stock's recent pullback. The insider story is the standout here. CEO Joseph Brown has been…
Protagonist Therapeutics heads into its May 7 Q1 earnings with options markets flashing the most defensive signal of the past year. The put/call ratio has surged to 1.48 — nearly at its 52-week high and almost two…
Avalo Therapeutics reports on May 8 carrying one of the most contested short-interest profiles in small-cap biotech. The bear trade is substantial. Short interest has climbed to 30.7% of the free float — up 29% over…
GSM heads into the market reaction to its Q1 2026 results with a modest positive surprise already on the tape — and a stock that has quietly rebuilt momentum over the past month. Revenue of $347.7M beat the consensus…
Lumentum Holdings enters its May 7 earnings report riding a remarkable short squeeze. The stock is up 26% over the past week and 20% over the past month, closing at $994.56 — yet options traders are hedging hard into…
The Chemours Company walks into its Q1 2026 earnings report with one of the sharpest momentum stories in the chemicals sector — up 30% in a month — and options traders who appear to be chasing the move rather than…
Rapid7 reports Q1 2026 results on May 7 against a backdrop of rising short pressure, beaten-down analyst targets, and a stock that has lost more than half its value this year. Short sellers have grown more aggressive…
National Storage Affiliates Trust reports Q1 2026 results on May 8 as a stock that has dramatically outrun analyst expectations — a tension that frames the entire setup into the print. The stock's 7% gain over the past…
Global Net Lease heads into its May 7 earnings print with the options market signalling unusual calm — while short sellers have quietly built positions over the past month. The most notable shift in positioning is not…
Community Healthcare Trust heads into its May 6 earnings release with options markets flashing unusually bullish positioning — a sharp contrast to a stock that has spent most of the past year under pressure. The…
Kimball Electronics reported fiscal Q3 results after the close on May 5, delivering an EPS print that landed right on consensus but revenue that fell short — a combination that frames today's earnings call as a test of…
Limbach Holdings heads into its Q1 2026 earnings print today with options traders signalling a decisive shift in conviction — and a price chart that has already moved aggressively to confirm it. The clearest signal…
Rayonier Advanced Materials walks into its Q1 2026 print today with one striking contradiction: a near-perfect history of beating analyst estimates, and a stock that has fallen 13% in the past month to $9.29. The most…
